Compass Therapeutics Chief Accounting Officer Neil Lerner buys 20,000 shares for $18,400

CMPX•2026-10-02

Chief Accounting Officer Neil Lerner bought 20,000 Compass Therapeutics shares at $0.92 each for $18,400. His beneficial ownership rose to 420,000 shares.

1. Share purchase

Compass Therapeutics Chief Accounting Officer Neil Lerner bought 20,000 common shares at $0.92 each, for a total of $18,400. His beneficial ownership increased to 420,000 common shares following the transaction.

Sources

Compass Therapeutics Chief Accounting Officer Neil Lerner buys 20,000 shares for $18,400

Sec

Compass Therapeutics Chief Accounting Officer Neil Lerner buys 20,000 shares for $18,400

1. Share purchase

Related News

Rivian reaffirms 2026 delivery guidance of 65,000-70,000 vehicles

French President Macron to chair G7 leaders' videocall this Friday on energy markets

Haoxin Holdings taps broker to pursue acquisition of US trucking company

Sources

Compass Therapeutics Chief Accounting Officer Neil Lerner buys 20,000 shares for $18,400

NN Inc prices unregistered PIPE at $3.30 per share for $50 million net proceeds

Copper crawls higher on softer dollar, but investors wary about demand